#ACVC27 abstract submission deadline extended to 3 November.
Submit your science and share work that could shape care under pressure.
Clinical cases close on 5 November. Congress grants are available for qualifying presenters; apply by 15 December. escardio.org/events/congress…#ACVC_ESC#cvacute@ACVCPresident
#ImageOfTheWeek by Hussein Almejbel, Monther ALahmad and Samah Ali from Security Forces Hospital, Makkah, Kingdom of Saudi Arabia.
What is the cause of persistent hypertension in this young woman ow.ly/M4ny5101AWk
One month ago, Europe kicked off its very first #EUScreeningWeek.
450+ activities. All 27 🇪🇺Member States. Around 900 places to check your numbers.
To every volunteer, pharmacist, doctor, nurse, student &partner who brought prevention closer to people: thank you.
#KnowYourNumbers
🤰🫀 Choosing the right cardiac imaging test during pregnancy isn’t always straightforward!
When is echo enough? When should we consider CMR, CT or nuclear imaging?
🎥 Explore these questions in the new #EACVI#HITbite by Dr @aniela_petrescu!
💡 Want to dive deeper? Don’t miss the upcoming #EACVI Webinar, featuring:
🎙️ Host: Prof Ana Maria G Almeida 🇵🇹
👩⚕️ Speakers:
Dr Julia Grapsa 🇺🇸
Prof L Elif Sade 🇺🇸
📅 29 October 2026
⏰ 18:00–19:00 CET
🔗 esc365.escardio.org/event/27…#EACVIHIT#echofirst#whyCMR#CCT#CVNuclear#ThinkPET
Ready to share your cardiovascular pharmacotherapy research?
European Heart Journal – Cardiovascular Pharmacotherapy welcomes original clinical, epidemiological, and translational research advancing our understanding of cardiovascular drug therapy.
From clinical trials and real-world studies to drug safety, pharmacogenomics, and pharmacoeconomics, share your research with the international cardiovascular community.
Read the advance articles 👓 ow.ly/pR6o5101kQv
Submit your paper here 👉 ow.ly/BUBA5101kQw#EHJPharmacotherapy@AgewallStefan@FeliceGragnano@EditorEHJCVP
What makes #EAPCI27 unmissable? Hear it from the community.
Discover what brings experts together to share knowledge, challenge perspectives & learn from each other.
The Scientific Programme is live! Explore it & register by 17 December to save the most esc365.escardio.org/EAPCI-Co…#EAPCI@EAPCIPresident
🩷 What could you take away from #EACVI26?
Hear from our Programme Chairs on the expert learning, practical sessions and scientific exchange awaiting you in Milan. Swipe through their thoughts and start planning your own congress experience.
Explore the programme and register by 3 November to save 👉 ow.ly/SEal5101its#EACVI@EACVIPresident@VDelgadoGarcia@rmanka_@NAjmoneMarsan
Which of the following is not a "red flag" useful in identifying an "athlete's heart"? ow.ly/MCbp5101fyK
a) Myocardial scar
b) LV wall thickness >12 mm with systolic or diastolic dysfunction
c) LV wall thickness >14 mm with impaired systolic function
d) Exercise-induced arrhythmias
e) LV wall thickness >14 mm with impaired diastolic function
Share your answer below 👇
#ESCTVToday
🎙️ New #ESCCardioTalk
Using gap to goal to guide treatment escalation: lessons from VICTORION-Challenge and beyond
How can measuring the gap to LDL-C goal help us decide when and how to escalate lipid-lowering therapy?
@ProfKausikRay and Irene Karungi discuss.
🎧 Listen on your favourite app 👉 esc365.escardio.org/event/28…#Cardiology#Lipids#LDL#CVprev
You still have time to apply! The deadline for the ESC Fund Basic Cardiovascular Science Course 2027 has been extended to 28 October.
What makes the ESC Fund Basic Cardiovascular Science Course a unique learning experience? Course Director Prof. Paul Evans highlights the enthusiasm and collaboration between professors and students, while past participants share their experiences.
👉 Hear more from the students : ow.ly/c1ez50ZZztE
This course was created by ESC Fund in partnership with the Novo Nordisk Foundation.
🔗 Apply today : ow.ly/pcwA50ZZztF#CardioResearch@novonordiskfond
Cardiovascular disease burden has declined across Europe, but important sex-specific inequalities persist
Our analysis of 55 ESC countries from 1990 to 2023 shows substantial reductions in cardiovascular mortality in both women and men.
However, these improvements mask distinct patterns of inequality: men continue to experience more than twice the rate of premature cardiovascular mortality, while women show substantially greater variation in cardiovascular disease burden between countries.
Read the article : ow.ly/9Q575100xxl
Access your local data on ESC Atlas : ow.ly/POgY5100xxm#CardiovascularHealth#HeartHealthEquity#EHJ@EAPCPresident